In-Silico evidence for two receptors based strategy of SARS-CoV-2
E. Milanetti, M. Miotto, L. Di Rienzo, M. Monti, G. Gosti, G. Ruocco
Abstract
We propose a novel numerical method able to determine efficiently and effectively the relationship of complementarity between portions of protein surfaces. This innovative and general procedure, based on the representation of the molecular iso-electron density surface in terms of 2D Zernike polynomials, allows the rapid and quantitative assessment of the geometrical shape complementarity between interacting proteins, that was unfeasible with previous methods. We first tested the method with a large dataset of known protein complexes obtaining an overall area under the ROC curve of 0.76 in the blind recognition of binding sites and then applied it to investigate the features of the interaction between the Spike protein of SARS-CoV-2 and human cellular receptors. Our results indicate that SARS-CoV-2 uses a dual strategy: its spike protein could also interact with sialic acid receptors of the cells in the upper airways, in addition to the known interaction with Angiotensin-converting enzyme 2.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular basis for SARS-CoV-2 spike affinity for human ACE2 receptor
J. M. Delgado, N. Duro, … S. Varma·bioRxiv·Sep 10, 2020
- SARS-CoV-2 comprehensive receptor profiling: mechanistic insight to drive new therapeutic strategies
S. M. Brockbank, R. Faba-Rodriguez, … J. Freeth·bioRxiv·Mar 11, 2021
- Biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
R. Chowdhury, C. D. Maranas·bioRxiv·Mar 30, 2020
- ACE2 fragment as a decoy for novel SARS-Cov-2 virus
Fabiana Renzi, Dario Ghersi·bioRxiv·Apr 6, 2020
- The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor
Esther S. Brielle, Dina Schneidman‐Duhovny, Michal Linial B·VirusesPeer-reviewed·Apr 30, 2020
- Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
I. Lui, X. X. Zhou, … J. A. Wells·bioRxiv·May 21, 2020